07 Jan 2001

Neuronika® (Neuronika® Kapseln) - Deutschland

Updated: 07 Jan 2001

Neuronika®

Angst- u. Spannungszustände, Antriebsarmut, Dysphorie, Konzentrations- u. Leistungsschwäche, protrahiertes Entziehungssyndrom nach Alkoholabusus.

Neuronika® Description, Presentation and Dosage

Neuronika® Description

Neuronika® Drug Class Description

Einzelstoffe

Neuronika® Drug Description

1 Kps. enth.: (±)-5,6-Dihydro-4-methoxy-6-styryl-pyron (D,L-Kavain) 200 mg.

Neuronika® Generic Name

Neuronika® Kapseln

Neuronika® Presentation

Neuronika® Presentation

Neuronika®

Neuronika® Manufacturer

Klinge

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

Neuronika® Dosage

Neuronika® Adult Dosage

Rüböl, Partiell hydrierte Pflanzenöle, Gelbes Wachs, Hydriertes Sojabohnenöl, Sojalecithin, Gelatine, Glycerol, Farbstoffe E 171, E 172.

Neuronika® Precautions, Reactions and Contraindications

Neuronika® Special Precautions

Neuronika® Adverse Reactions

Neuronika® Adverse Reactions

Gr 1 .

Related Drugs - Psychiatry/Mental Health

Back to top